Literature DB >> 16908708

Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.

R Klingenberg, C Zugck, R Becker, D Schellberg, G Heinze, R Kell, A Remppis, W Schoels, H A Katus, T J Dengler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16908708      PMCID： PMC1861173          DOI： 10.1136/hrt.2005.076117

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.

Authors:  B F Uretsky; K Thygesen; P W Armstrong; J G Cleland; J D Horowitz; B M Massie; M Packer; P A Poole-Wilson; L Ryden
Journal:  Circulation       Date:  2000-08-08       Impact factor: 29.690

2.  Cost-effectiveness of implantable cardioverter-defibrillators.

Authors:  Gillian D Sanders; Mark A Hlatky; Douglas K Owens
Journal:  N Engl J Med       Date:  2005-10-06       Impact factor: 91.245

3.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

4.  High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.

Authors:  K Maeda; T Tsutamoto; A Wada; N Mabuchi; M Hayashi; T Tsutsui; M Ohnishi; M Sawaki; M Fujii; T Matsumoto; M Kinoshita
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

5.  B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.

Authors:  Rudolf Berger; Martin Huelsman; Karin Strecker; Anja Bojic; Petra Moser; Brigitte Stanek; Richard Pacher
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690
  5 in total
  5 in total

1.  Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?

Authors:  Jennifer Franke; Lutz Frankenstein; Dieter Schellberg; Amer Bajrovic; Jan Sebastian Wolter; Philipp Ehlermann; Andreas O Doesch; Manfred Nelles; Hugo A Katus; Christian Zugck
Journal:  Clin Res Cardiol       Date:  2011-07-16       Impact factor: 5.460

Review 2.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

3.  Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events.

Authors:  Tobias Simon; Ruediger Becker; Frederik Voss; Olympia Bikou; Melanie Hauck; Manuela Licka; Hugo A Katus; Alexander Bauer
Journal:  Clin Res Cardiol       Date:  2008-01-14       Impact factor: 5.460

Review 4.  Risk Stratification of Sudden Cardiac Death After Acute Myocardial Infarction.

Authors:  An H Bui; Jonathan W Waks
Journal:  J Innov Card Rhythm Manag       Date:  2018-02-15

Review 5.  Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death.

Authors:  Zornitsa Shomanova; Bernhard Ohnewein; Christiane Schernthaner; Killian Höfer; Christian A Pogoda; Gerrit Frommeyer; Bernhard Wernly; Mathias C Brandt; Anna-Maria Dieplinger; Holger Reinecke; Uta C Hoppe; Bernhard Strohmer; Rudin Pistulli; Lukas J Motloch
Journal:  J Clin Med       Date:  2020-02-20       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.